Navigation Links
Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
Date:5/15/2008

ndpoint of all-cause mortality combined with cardiovascular hospitalization as compared to placebo. The pre-specified secondary endpoints were death from any cause, cardiovascular death and hospitalization for cardiovascular reasons. The pre-specified safety endpoint was the incidence of treatment emergent adverse events (time of observation for treatment emergent adverse events) including: all adverse events, serious adverse events, adverse events leading to study drug discontinuation.

The atrial fibrillation or atrial flutter patient population studied were either greater than or equal to 75 years (with or without cardiovascular risk factor) or were <75 years with at least one additional cardiovascular risk factor (hypertension, diabetes, previous cerebrovascular event, left atrium size >50 mm or left ventricular ejection fraction <40 percent). Patients suffering from decompensated heart failure were excluded from the study. Patients were randomized to receive Multaq(R) 400 mg BID or placebo, with a maximum follow-up of 30 months.

The countries which enrolled patients included: Argentina, Australia, Austria, Belgium, Canada, Chile, China, Czech Republic, Finland, Germany, Greece, Hong Kong, Hungary, India, Israel, Italy, Malaysia, Mexico, Morocco, New Zealand, Norway, Philippines, Poland, Portugal, Russia, South Africa, Singapore, South Korea, Spain, Sweden, Taiwan, Thailand, The Netherlands, Tunisia, Turkey, the UK, the US.

About Multaq(R) (dronedarone)

Dronedarone (brand name Multaq(R)) is an investigational new treatment for patients with atrial fibrillation, which has been discovered and developed by sanofi-aventis for the prevention and treatment of patients with atrial fibrillation or atrial flutter. Dronedarone is a multi-channel blocker that affects calcium, potassium and sodium channels and has anti-adrenergic properties. Dronedarone does not contain the iodine radical and did not show any evidence of thyroid or pulmonary toxic
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
2. Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
3. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
4. Hospital Launches Landmark Emergency Medicine Project
5. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
6. Viatronix V3D-Colon Utilized in Another Landmark Study
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization
9. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
10. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
11. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)...  EHE International, the recognized leader in preventive medicine ... today announced that Dignity Health Medical Group Nevada, LLC  ... been named an EHE-certified preventive care center. Through Dignity, ... region now have greater access to EHE,s preventive ... "EHE is proud to add Dignity Health ...
(Date:7/21/2014)... 21, 2014 According ... Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, ... global microfluidic device market was valued at USD 3,005 ... a CAGR of 13.8% from 2014 to 2020, to ... 2020. Browse the full E-Clinical Solution Software Market ...
(Date:7/21/2014)... -- By order of the U.S. Bankruptcy Court, Tiger Group,s ... and optical equipment, designer eyeglass frames, and other assets of ... Services LLC. Online bidding opens July 21 at ... auction style, on July 28 beginning at 10:30 a.m. (ET). ... July 25 th and 26 th at 12 ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5Auction Set For Assets Of National Optical Services Company 2
... CAESAREA, Israel, May 2, 2012 Angioslide ... announced that it has received FDA 510(K) clearance for ... Disease in below the knee (BTK) vasculature.  The new ... potential use of PROTEUS technology.   Angioslide,s ...
... NBIX ) today announced its financial results for ... of 2012, the Company reported net loss of $0.9 million, ... of $2.9 million, or $0.05 income per share, for the ... results is primarily due to the Company,s VMAT2 program moving ...
Cached Medicine Technology:Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device 2Neurocrine Biosciences Reports First Quarter 2012 Results 2Neurocrine Biosciences Reports First Quarter 2012 Results 3Neurocrine Biosciences Reports First Quarter 2012 Results 4Neurocrine Biosciences Reports First Quarter 2012 Results 5Neurocrine Biosciences Reports First Quarter 2012 Results 6
(Date:7/22/2014)... July 22, 2014 The hair ... are now offering robotic assisted laser therapy and ... solutions for men and women suffering from hair ... they now offer Follicular Unit Extraction (FUE) procedures ... robot. With this new technology, their doctors use ...
(Date:7/21/2014)... to target and kill cancer cells could boost the ... help avoid amputation, a new study reports. , Scientists ... effectiveness of a genetically engineered version of the virus ... of the virus alongside isolated limb perfusion chemotherapy ... or leg as an alternative to amputation was ...
(Date:7/21/2014)... 2014 MillionaireCasket.com, a well-known casket manufacturer from ... caskets to its website. In addition to this, the ... off) for all these brand new items. , MillionaireCasket.com ... great caskets for its current and prospective clients. ... and oak caskets and more. According to the company’s sales ...
(Date:7/21/2014)... CA (PRWEB) July 21, 2014 Cannabis ... four major cannabis events this summer. During these festivals, ... by providing additional information and resources to attendees in ... educate the public on the legitimate and beneficial side ... Cannabis Cup in San Francisco, the Kush Expo in ...
(Date:7/21/2014)... to hate losing. , Unfortunately, it,s also human ... solid strategy and thus increasing your chances of losing ... a Brigham Young University study published this week by ... based on an analysis of two decades of data ... whether coaches adjusted their personnel following games where the ...
Breaking Medicine News(10 mins):Health News:WeGrowHair.com/PAI Medical Group Introduces Robotic Assisted Laser Therapy to Treat Hair Loss 2Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:Cheap Maple Caskets Recently Added To China Casket Manufacturer MillionaireCasket.com’s Product Line 2Health News:Cannabis Now Magazine Hits the Marijuana Festival Circuit and Sponsors Two Major Events 2Health News:'Moral victories' might spare you from losing again 2
... alcohol quotient is highly conducive for the cognitive development ... has suggested//. Infact, even moderated alcohol intake during the ... child. ,The study conducted by the University of ... has shown that those children, whose mothers had indulged ...
... Geneva – A nod has been given by the administration in ... research and development//. This is indeed a quantum leap in this ... it will also infuse renewed thrust in the area of drug ... novel methods to source drugs, based on the funding. ...
... some alarming world statistics regarding the use of tobacco amongst ... year olds consume tobacco and its products. , ,These ... World Health Organization's World No Tobacco Day; on May 31st. ... in any form or disguise,'' conveying cigarette smoking in any ...
... that nearly a third of the 32,000 terminations by women ... abortion pill, also known as EMA early medical abortion. ... abortion pill in Britain has reached an all time high ... the number of women, which it treated with EMA, rose ...
... students and junior medical doctors of the Medical College ... have decided to not to run the outpatient departments ... doctors have however promised not to cause any inconvenience ... a ‘parallel OPD’s’ for the benefit of patents. A ...
... much commotion across the world and it has drastically affected the ... increase in demand for chicken// and the sales are slowly picking ... in its recuperation stage. ,Mohamed Al Shafei, director of ... has suffered a great deal in the past with a large ...
Cached Medicine News:Health News:Record Number Of Women Use Abortion Pills 2Health News:Agitating Doctors Call For Two Day Shut Down Of OPD’ 2
0.5X1.5mm Tip, Oval Shape; in Titanium....
0.5X2.0mm Tip, Oval Shape; in Titanium....
2.5x8mm Spatula Combined with 8mm Blade; in stainless steel....
0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
Medicine Products: